Esoteric Testing Market
Report ID: SQMIG35A2910
Report ID: SQMIG35A2910
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A2910 |
Region:
Global |
Published Date: November, 2024
Pages:
206
|Tables:
72
|Figures:
72
Esoteric Testing Market size was valued at USD 35.5 Billion in 2024 and is poised to grow from USD 38.55 Billion in 2025 to USD 74.6 Billion by 2033, growing at a CAGR of 8.6% during the forecast period (2026–2033).
The market growth is driven by growing demand for early diagnosis, increasing demand for safe methods of cancer diagnosis and increasing incidence of cancer. As National Center for Biotechnology Information (NCBI) estimates about 1.95,000 million cancer diagnoses and 609,820 cancer deaths in the US. Furthermore, the introduction of advanced latent testing technology in independent laboratories is expected to expand the market.
With technological advances such as real-time polymerase chain reaction, next-generation sequencing, increased demand for esoteric diagnostics by surgeons and patients is expected to become paramount leading to increased demand for advanced diagnostic testing. Unlike conventional blood or urine tests, occult tests are usually administered from a laboratory equipped with the necessary equipment. These tests can be very helpful in a particular clinical situation or scientific research because it is more specific and effective therefore, although generally more is required due to increased therefore costs.
Market snapshot - 2026-2033
Global Market Size
USD 32.69 Billion
Largest Segment
Oncology
Fastest Growth
Genetic Testing
Growth Rate
8.60% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Esoteric Testing Market is segmented by Technology, Type, Specimen, End User, and Region. Based on Technology, the market is segmented into Chemiluminescence Immunoassay, Enzyme-Linked Immunosorbent Assay Real-Time PCR, DNA Sequencing and Next-Generation Sequencing, Flow Cytometry, Chromatography and Mass Spectrometry, and Other Technologies. Based on Type, the market is segmented into Oncology Testing, Autoimmune Disease Testing, Infectious Disease Testing, Endocrinology Testing, Genetic Testing, Neurology Testing, Toxicology and Drug Monitoring Testing, Other Types of Testing. Based on Specimen, the market is segmented into Blood, Serum, and Plasma, Urine, and Other Specimens. Based on End User, the market is segmented into Independent and Reference Laboratories, and Hospital-Based Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
The oncology segment led the market and accounted for 28.03% of the global revenue in 2023. The dominance can be attributed to the rising incidence of cancer and high demand for occult diagnostic tests. It is expected that cancer the number of copies received will increase to 7 million. Thus, the increasing number is expected to increase the acceptability of esoteric testing in cancer patients, thereby growing the segments. Many programs and programs are being developed by private and public organizations to cure cancer and increase life expectancy as well.
The genetic testing segment is expected to register the fastest CAGR of 12.18% during the forecast period. The growth of the segment is driven by advances in genomic techniques, increased awareness of personalized medicines and increasing demand for genetic testing with increased awareness for early diagnosis in population. According to 2023 NCBI data, there were currently 76,326 genetic studies 76,083 for review and 243 for research purposes forecast. Furthermore, increasing incidence of genetic diseases and increasing need for research is expected to fuel the market growth. For example, according to the American Society of Clinical Medicine, newborn screening programs in the United States screen children for more than 60 disorders.
Chemiluminescence immunoassay dominated the market with the highest revenue share in 2023. This dominance of the segment is due to the high sensitivity of the assay in detecting hormones, proteins, antibodies, nucleic acids etc. In addition, it supports multiple combinations, capable of measuring multiple analytes simultaneously. Furthermore, significant advantages associated with chemiluminescence immunoassays, such as high reagent stability and conjugate stability, complete compatibility with immunological assay protocols, rapid analytical signal acquisition and reduced incubation time further enhance fraction growth.
Enzyme-linked immunosorbent assay (ELISA) is expected to register the fastest CAGR during the forecast period. ELISA-based assays enable the detection and measurement of specific proteins and antibodies in a sample, making them a common diagnostic tool. Moreover, it is expected that tests and analyzes with technological advances an increasingly will use these features to conduct analytics applications applications. The ELISA analyzers market is driven by the increasing need for technological advancement and automation. ELISA analyzers are a commonly used diagnostic tool that can detect and measure specific protein antibodies in a sample providing significant market growth.
To get detailed segments analysis, Request a Free Sample Report
North America region in the market accounted for 31.22% in 2023. Government subsidies for high quality healthcare, availability of coverage, increased purchasing power, increased incidence of infections and diseases such as cancer are important enhancers in this category. This can be attributed to the anticipated growth of the market owing to well-established healthcare infrastructure, increased purchasing power and moving occult test approval rates. The esoteric testing market in the U.S. is expected to grow slightly and is expected to increase during the forecast period owing to healthcare initiatives, rising prevalence of diabetes and favorable conditions for market expansion in the country.
Asia-Pacific in the market was anticipated to witness substantial growth during the forecast period. Additionally, developing countries such as India and China have opportunities for growth due to high patient volumes and increasing number of established healthcare providers, healthcare utilization trends the front comes from increased government support for chronic disease diagnosis and treatment. China's healthcare system is facing a severe test due to rising healthcare costs and high spending. In addition, a growing number of government programs aimed at providing diagnostic services, rapid development of enzyme-linked immunoassay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR) are expected to drive market growth in China.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Incidence of Chronic Diseases
Advances in Genomic and Proteomic Technologies
High Cost of Specialized Tests
Limited Payment Terms
Request Free Customization of this report to help us to meet your business objectives.
A notable example of a strategic partnership in the esoteric testing market is between Quest Diagnostics and Memorial Sloan Kettering Cancer Center (MSKCC). This collaboration focuses on advanced oncology testing and includes Quest's lab capabilities expands its MSKCC expertise in cancer genomics. Together, it has developed research that helps identify genetic mutations and abnormalities associated with various cancers, and helps physicians develop personalized treatment plans.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, there has been tremendous growth in the esoteric testing market, driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular disease and diabetes, which require more advanced testing than routine testing. Cutting-edge genomic and proteomic technologies, such as next-generation sequencing (NGS) and mass spectrometry, enhance esoteric testing capabilities, further enhancing market expansion but at the expense of specialized testing of this and limited coverage in many health systems is a significant limitation. The esoteric testing market is expected to continue to grow as demand for specialized diagnostics increases, with innovations in molecular testing and increased focus on precision drug development will determine future development.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 35.5 Billion |
| Market size value in 2033 | USD 74.6 Billion |
| Growth Rate | 8.6% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Esoteric Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Esoteric Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Esoteric Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Esoteric Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
